Document:

Exhibit 10.5

 

AMENDMENT NO. 1

TO

AVIZA, INC.

2003 EQUITY
INCENTIVE PLAN

Pursuant to the
authority reserved to the Board of Directors (the “Board”) of Aviza, Inc., formerly Aviza
Technology, Inc. (the “Company”),
a corporation organized under the laws of State of Delaware, under Section 15
of the Company’s 2003 Equity Incentive Plan (the “Plan”), the Board hereby amends the Plan as
follows.

1.             Effective as of December 15, 2006, Section 2 of the Plan
is hereby amended to incorporate a new definition following the definition of “Employee,”
re-lettering each subsequent definition accordingly, to read in its entirety as
follows:

“(l)   “Equity
Restructuring” shall mean a non-reciprocal transaction between the Company
and its stockholders, such as a stock dividend, stock split, spin-off, rights
offering or recapitalization through a large, nonrecurring cash dividend, that
affects the shares of Stock (or other securities of the Company) or the share
price of Stock (or other securities) and causes a change in the per share value
of the Stock underlying outstanding Awards.”

2.             Effective as of December 15, 2006, Section 13(a) of the
Plan is hereby amended to read in its entirety as follows:

“(a)         In the
event of any combination or exchange of shares, merger, consolidation or other
distribution (other than normal cash dividends) of Company assets to
stockholders, or any other change affecting the shares of Stock or the share
price of the Stock other than an Equity Restructuring, the Committee shall make
such proportionate adjustments, if any, as the Committee in its discretion may
deem appropriate to reflect such change with respect to (i) the aggregate
number and kind of shares that may be issued under the Plan (including, but not
limited to, adjustments of the limitations in Sections 3 and 6(c)); (ii) the
terms and conditions of any outstanding awards (including, without limitation,
any applicable performance targets or criteria with respect thereto); and (iii)
the grant or exercise price per share for any outstanding awards under the
Plan.  Any adjustment affecting an award
intended as “qualified performance-based compensation” as described in Section
162(m)(4)(C) of the Code shall be made consistent with the requirements of
Section 162(m) of the Code.”

3.             Effective as of December 15, 2006, Section 13 of the
Plan is hereby amended to incorporate a new subsection (c) following the
existing subsection (b) to read in its entirety as follows, with each
subsequent subsection re-lettered accordingly:

“(c)          In connection with the occurrence of
any Equity Restructuring, and notwithstanding anything to the contrary in
Section 13(a):

(i)                   The number and type of
securities subject to each outstanding award and the exercise price or grant
price thereof, if applicable, will be proportionately adjusted.  The adjustments provided under this Section
13(b)(i) shall

    

be
nondiscretionary and shall be final and binding on the affected Holder and the
Company.

(ii)                  The
Administrator shall make such proportionate adjustments, if any, as the Administrator
in its discretion may deem appropriate to reflect such Equity Restructuring
with respect to the aggregate number and kind of shares that may be issued
under the Plan (including, but not limited to, adjustments of the limitations
in Sections 3 and 6(c)).”

4.             Notwithstanding anything in this Amendment No. 1 to the
Plan to the contrary, this Amendment No. 1 to the Plan shall not apply to, and
instead Sections 13(a) and 13(b) of the Plan shall apply to, any award to which
the adoption of this Amendment No. 1 to the Plan by the Board would (A) result
in a penalty tax under Section 409A of the Code and the Department of Treasury
proposed and final regulations and guidance thereunder or (B) cause any
Incentive Stock Option to fail to qualify as an “incentive stock option” under
Section 422 of the Code.Exhibit 4.3

Resolution Number 14 of
the General Meeting of the Shareholders of sanofi-aventis held on May 31, 2005

(Free
translation.  French original prevails.)

FOURTEENTH RESOLUTION 

Delegation to the Board of Directors of authority to grant options to subscribe
for or purchase shares

The General Meeting, voting on the quorum and majority
conditions for Extraordinary Meetings,
having reviewed the Directors’ Report and Statutory Auditors’ Special Report:

1.     authorizes the Board of
Directors, under articles L.225-177 to L.225-185 and L. 225-129-2 of the
Commercial Code, to grant, on one or more occasions, in favor of members of the
personnel to be chosen by the Board of Directors from among the employees and
corporate officers of the company or of companies or groupings related to the
company, on the terms specified in article L.225-180 of said Code, options
giving entitlement to subscribe for new shares in the company to be issued in
the form of an increase in its capital, and options giving entitlement to purchase
shares in the company obtained by the company repurchasing its own shares on
the terms laid down by the law;

2.     resolves that options to
subscribe for or purchase shares granted by virtue of the present authorization
may not give entitlement to a total number of shares exceeding 2.5% of the
share capital as of the day the decision is made by the Board of Directors, and
that the aggregate par value of capital increases resulting from the exercise
of options to subscribe for shares granted under the present delegation will
count towards the overall ceiling specified in section 3 of the 9th resolution of the present meeting;

3.     resolves that the price
payable on the exercise of the options to subscribe for or purchase shares will
be set in accordance with the law by the Board of Directors on the day the
options are granted; such price may not be lower than the average of the first
quoted prices of the company’s shares on the Euronext Eurolist during the
twenty trading sessions preceding the day on which the options to subscribe for
shares are granted. If the company carries out any of the transactions
specified in article L.225-181 of the Commercial Code, the Board of Directors
will, on the terms stipulated by the regulations then in force, take the necessary
measures to protect the interests of the grantees by adjusting the number and
price of the shares that may be obtained on exercise of options granted to
grantees so as to take account of the impact of the transaction in question;

4.     duly notes that the present
delegation entails the express waiver by the shareholders, in favor of the
grantees of options to subscribe for shares, of their preemptive rights
relating to the shares that are to be issued as and when said options are
exercised. The increase in the share capital resulting from the exercise of the
options to subscribe for shares will be definitively completed by mere
declaration that the option is exercised accompanied by the subscription form
and full payment, which may be made in cash or by set-off of debts of the
company;

5.     consequently,
confers full powers on the Board of Directors to implement the present
authorization, and in particular to:

·                  establish a list of grantees of
options, showing the number of options granted to each;

 

·                  set the terms
and conditions of the options, and in particular:

–                 the term of
validity of the options, it being understood that the options must be exercised
within a maximum period of 10 years;

–                 the exercise
date(s) or period(s) of the options, it being understood that the Board of
Directors may (a) bring forward the exercise date(s) or period(s) of the
options, (b) extend the exercisability of the options, or (c) amend the dates
or periods during which shares obtained by exercise of options may not be
transferred or converted into bearer shares;

–                 any clauses
prohibiting immediate resale of some or all of the shares provided that the
period for which the shares must be retained may not exceed three years from
exercise of the option;

·                  where appropriate, limit, suspend,
restrict or prohibit the exercise of options or the transfer or conversion into
bearer shares of shares obtained by the exercise of options during certain
periods or with effect from certain events; such decision may relate to some or
all of the options or shares or to some or all of the grantees;

·                  decide on the date, which may be
retrospective, from which the new shares resulting from the exercise of options
to subscribe for shares will rank for dividend;

6.     resolves that the Board of
Directors, with authority to subdelegate within the law, will have full powers
to duly record the completion of capital increases to reflect the amount of
shares actually subscribed by the exercise of options to subscribe for shares,
amend the bylaws accordingly, and, at its sole discretion and as it sees fit,
charge the costs of the capital increases against the share premium arising
thereon and withhold from this premium the sums necessary to increase the legal
reserve to one-tenth of the new share capital after each capital increase, and
accomplish all formalities necessary for the listing of the securities thereby
issued, make all declarations with the relevant bodies and generally do all
that is necessary;

7.     resolves
that this authorization cancels with effect from this day any unused portion of
any previous delegation to the Board of Directors of authority to grant options
to subscribe for or purchase shares. It is granted for a period of twenty-six
months from this day.Exhibit 4.4

Rules
and Regulations of Sanofi-Aventis Stock Option Plan 2006

December
2006

STOCK
OPTION SUBSCRIPTION PLAN OF SANOFI-AVENTIS

RULES OF
THE 6TH PLAN

 

**********

 

	
  

  	
  1.

  	
  PARTICIPANTS

  
	
   

  	
   

  
	
   

  	
  2.

  	
  DURATION OF THE PLAN

  
	
   

  	
   

  
	
   

  	
  3.

  	
  STOCK OPTION EXERCISE

  
	
   

  	
   

  
	
   

  	
  4.

  	
  SALE OF SHARES

  
	
   

  	
   

  
	
   

  	
  5.

  	
  SHARE RIGHTS

  
	
   

  	
   

  
	
   

  	
  6.

  	
  OPTION PRICE ADJUSTMENT

  
	
   

  	
   

  
	
   

  	
  7.

  	
  FOREIGN PARTICIPANTS

  

 

Free Translation of French
version

December 2006

(The French
version prevails)

The Board of Directors of
sanofi-aventis was authorized by a General Meeting of its Shareholders held on
May 31, 2005, according to Articles L.225-177 to L.225-185 and L.225-129-2 of
the French Commercial Code to set up stock option purchase or subscription
plans for the whole of the sanofi-aventis group. By sanofi-aventis group we
mean all companies or groupings of economic interest defined by Article
L.225-180 of the aforementioned code.

Following the proposal of
its Chairman, the Board of Directors has laid down the following rules of the
stock option subscription plan with effect from December 14, 2006.

1.      PARTICIPANTS

Upon the recommendation of the Chairman of sanofi-aventis acting upon
the advice of the Compensation, Appointments and Governance Committee, the
grant of options to subscribe shares of sanofi-aventis to a list of identified
employees and corporate officers and the number of options granted to each such
participants is approved by the Board of Directors.

The rights granted are not transferable unless the options are exercised.

2.      DURATION OF THE PLAN

Sanofi-aventis’ Stock Option Plan has a duration of ten years from the
date of the approval of the Board of Directors on December 14, 2006. It will
expire on December 14, 2016.

3.      STOCK OPTION EXERCISE

The exercise of the options, also called “exercise of the options to
subscribe shares” is not allowed during the first four years following the
Board of Directors’ approval on December 14, 2006.

 

The options can be exercised, on one or more occasions as the
participants see fit, at any time between December 15, 2010 and December 14,
2016 inclusive.  Thereafter, the options
will lapse.

Unless otherwise decided by the General Management of the Company in
exceptional cases, any participant irrevocably loses his/her rights to exercise
his/her options in the following cases:

–                 In
the event of resignation before the exercise date. Revocation of option rights
takes effect on the day of notice of resignation; and

–                 In
the event of dismissal for serious or gross misconduct. Revocation of option
rights takes effect on the day of notice of the dismissal.

The Company reserves the right to temporarily suspend the exercise of
the options, in particular when there are certain changes in the capital
structure of sanofi-aventis.

 

Exceptions :

3.1                       If
a participant retires  or takes
early retirement (including under the early retirement plan in
connection with the Group-wide framework agreement dated December 9, 2004), at
normal retirement age or earlier or later with the agreement of the Company, he
keeps his/her option rights until their expiration, that is December 14, 2016.

3.2                       Notwithstanding
the four-year period mentioned under Article 3, Paragraph 1, if an employee
becomes disabled, and such disability meets the
conditions of the second and third categories as defined by
Article L.341-4 of the French Social Security Code, the participant may
exercise his options. The participant keeps his/her option rights until their
expiration, that is December 14, 2016.

3.3                       Notwithstanding
the four-year period mentioned under Article 3, Paragraph 1, if an employee
dies during the option period, his/her heirs can exercise the options during
the six month period following the date of death.

4.      SALE OF SHARES

The sale of the shares through the exercise of the
options is possible from December 15, 2010.

However, any
participant mentioned under article 3.2 or the heirs of a participant who has
died mentioned under article 3.3 above are able to sell the corresponding
shares without waiting for the end of the four year holding period.

5.                 SHARE RIGHTS

The participant will have
rights to the shares that have been subscribed for upon exercise of the options
from the first day of the year during which they have been subscribed.

If he exercises his option between 1st January and the date on which the share
becomes ex-dividend for the dividend relating to the previous year, the
beneficiary will not to entitled to the dividend paid in the current year
relating to the previous year; he will be entitled to the dividend paid in the
following year relating to the current year.

6.      OPTION PRICE ADJUSTMENT

In the event of a redemption or reduction of share capital, a change in
the allocation of profits, a consideration-free issue of shares, an increase in
share capital by incorporation of reserves, profits or share premium, a
distribution of reserves, or any issue of equity 

 

instruments that includes subscription rights reserved for the
shareholders, the exercise price and the number of shares to which an option
gives right will be adjusted in order to take into account such issuance or
other capital transaction.

If such a situation is covered by existing law or regulation, such law
or regulation shall be applied.

If such a situation is not covered by existing law or regulation, the General
Meeting of Shareholders or the Board of Directors when deciding to conduct such
securities issuance or other capital transaction may adopt any measures
necessary to protect the rights of the holders of the stock-options, using by
analogy the rules and regulations which would govern similar cases.

7.      FOREIGN PARTICIPANTS

Some specific arrangements for the exercise of subscription options
will be notified to foreign participants on a case by case basis. Indeed, in
some foreign countries, local regulations particularly those relating to tax
and social securely require adjustments to the general terms described in these
rules.

The participant employees of American companies of the Group will have
the possibility to convert their ordinary shares into American Depositary
Receipts (“ADRs”) on exercise of their options.

**********

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00115-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00115-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00115-of-00352.parquet"}]]